eosine yellowish-(ys) has been researched along with Neuroendocrine Tumors in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Deshpande, V; Fernández-Del Castillo, C; Ferrone, CR; Ferrone, S; Ligorio, M; Lillemoe, KD; Mahadevan, KK; Sabbatino, F; Ting, DT; Vangel, M; Villani, V; Wargo, J; Warshaw, AL; Zhang, I | 1 |
1 other study(ies) available for eosine yellowish-(ys) and Neuroendocrine Tumors
Article | Year |
---|---|
Phosphorylated Histone H3 (PHH3) Is a Superior Proliferation Marker for Prognosis of Pancreatic Neuroendocrine Tumors.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Cell Proliferation; Coloring Agents; Disease-Free Survival; Eosine Yellowish-(YS); Female; Hematoxylin; Histones; Humans; Kaplan-Meier Estimate; Ki-67 Antigen; Male; Middle Aged; Mitotic Index; Neuroendocrine Tumors; Pancreatic Neoplasms; Phosphorylation; Proportional Hazards Models; ROC Curve; Survival Rate; Time Factors; Young Adult | 2016 |